For breastfeeding considerations, our guide on GLP-1 and breastfeeding covers the current safety data
Future prospects Today, the available pharmacological arsenal includes approaches to emerging conditions such as peripheral arterial disease and neurodegenerative disorders, further reinforcing the role of metabolic diseases in the pathophysiology of various conditions that have a profound impact on both quality of life and life expectancy in the population.60 Advances in knowledge and biochemical engineering are paving the way for intervention at multiple levels in the prevention and treatment of various complications, while also promoting therapeutic individualisation
Rising obesity rates risk eroding this foundation
Courses are often discussed in the range of four to 12 weeks, but this varies significantly and should be individualized
alternatives include SGLT2 inhibitors, DPP-4 inhibitors, insulin, or specialist allergy assessment for switching agents
GLP-1 medications may help regulate appetite signals, which can help some patients feel fuller longer and reduce excessive cravings as part of a structured plan